economy

We're trimming a big winner and buying the dip in a stock that shouldn't be down

We are making two trades Wednesday.

We're trimming a big winner and buying the dip in a stock that shouldn't be down

TL;DR

  • Jim Cramer's Charitable Trust is selling 15 shares of Goldman Sachs (GS) for a ~67% profit.
  • The trust is buying 65 shares of Johnson & Johnson (JNJ) to increase its position.
  • The sale of GS reduces its portfolio weight, while the purchase of JNJ increases it.
  • JNJ's purchase is driven by positive, unnoticed news about its Ottava robotic surgery system achieving a milestone in clinical studies.
  • Healthcare stocks are currently out of favor in an AI-driven market, but JNJ, along with other healthcare positions like Cardinal Health, is seen as a high-quality company with strong fundamentals.
  • JNJ's MedTech products and drugs are expected to support double-digit revenue growth by the end of the decade.

Continuer la lecture de l'article original